John Anthony DiBella II, the Chief Revenue Officer at Simulations Plus, Inc. (NASDAQ: SLP), executed a sale of 1,000 shares of the company's common stock on July 6, 2026. The total value of this transaction was $18,360. The shares were sold through multiple transactions at prices ranging from $18.34 to $18.39 per share. This sale was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. DiBella.
Following the transaction, Mr. DiBella directly holds 86,140 shares of Simulations Plus common stock. The insider sale comes as the stock trades near $18.27, showing strong momentum with gains of over 60% from its 52-week low of $11.09. According to InvestingPro analysis, the stock appears undervalued at current levels, with the company's Fair Value estimated significantly higher. The timing is notable as Simulations Plus is set to report earnings on July 9, just days away. InvestingPro subscribers have access to 12 additional exclusive tips about SLP, including detailed analysis of the company's financial health and growth prospects.
In other recent news, Simulations Plus Inc. has entered into a definitive agreement to be acquired by affiliates of Altaris, LLC in an all-cash transaction valued at approximately $375 million. Shareholders of Simulations Plus will receive $18.50 per share, marking a 26% premium to the company's 60-day volume-weighted average price. Following this announcement, William Blair downgraded the stock from Outperform to Market Perform. In parallel, Simulations Plus is expanding its collaboration with Nvidia, integrating the Nvidia BioNeMo Agent Toolkit into its AI platform for drug development. This partnership is expected to enhance their GPU-accelerated simulation and AI-assisted modeling workflows.
Additionally, Citizens has reiterated a Market Outperform rating on NRC Health stock, maintaining a price target of $23.00. This follows a review of recent financial results and investor focus areas at the firm's Healthcare Services Forum. These developments reflect ongoing strategic movements and partnerships within the healthcare and technology sectors.